FDA approves Merck’s RSV shot for infants, ramping... CNBC

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

CNBC June 09, 2025
Upvote 0 Downvote

Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

Read Full Article

Comments 0

Log in to post a comment.

No comments yet. Be the first to comment!

Related News
Source Information
CNBC

Published on June 09, 2025

Visit Source
Advertise with Us

Reach our audience with your ads